The 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 23) will bring together more than 2,300 experts from around the world to Sydney this week (July 24-27) to discuss advances in biomedical engineering.
Taking place across all four levels at ICC Sydney, the conference will feature more than 1,000 speakers and 1,200 poster displays, and bring about an estimated economic impact of A$7 million (US$4.7 million). A staggering 87 per cent of delegates are also international.
Anticipated keynote speaker, Nicholas Opie, will discuss his company’s advances with the Stentrode, a product that has just finished successful clinical trials. The Stentrode allows people with paralysis to control external equipment – such as phones and computers – with their minds.
Another key feature of EMBC 23 is the Women in Engineering forum, a first for the conference series. The forum will feature an all-female speaker line-up and fulfil the committee’s diversity, equity and inclusion objectives.
Australian event management company, The Arinex Group, managed all aspects of EMBC 23, including speaker management, programme management and accommodation.
